Status:
COMPLETED
Comparison of Outcomes Between Warshaw and Kimura Techniques for Spleen-preserving Minimally Invasive Distal Pancreatectomy
Lead Sponsor:
Zhejiang University
Conditions:
Distal Pancreatectomy
Spleen Preservation
Eligibility:
All Genders
Brief Summary
Spleen-persevering distal pancreatectomy (SP-DP) has been widely advocated as a routine procedure for benign or low-grade malignant tumors in the pancreatic body and tail, especially with a minimally ...
Eligibility Criteria
Inclusion
- pathological diagnosis of benign or low-grade malignant pancreas tumors.
Exclusion
- incomplete medical records,
- history of previous splenectomy,
- high-grade malignant pancreas tumors,
- conversion to open DP (ODP).
Key Trial Info
Start Date :
July 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
314 Patients enrolled
Trial Details
Trial ID
NCT06084975
Start Date
July 1 2018
End Date
December 31 2022
Last Update
October 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the First Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China, 310003